Skip to main content
Clinical Medicine logoLink to Clinical Medicine
. 2012 Dec;12(6):600. doi: 10.7861/clinmedicine.12-6-600

Acute oxalate nephropathy

WT Hinchliffe 1,, S Fenwick 1, K MacDougall 1
PMCID: PMC5922607  PMID: 23342420

We were referred a patient at a stage of partial resolution of acute kidney injury (peak serum creatinine 590 umol/l). A renal biopsy was performed (Fig 1). Acute oxalate nephropathy was diagnosed and Orilstat (Xenical®) was considered causal. Orlistat has been available over the counter in the UK since 2009 and its usage will increase. We highlight this adverse reaction and advocate monitoring biochemistry.

Fig 1.

Fig 1.

Renal biopsy of patient with acute kidney injury.


Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES